Skip to main content
Log in

The serotonin theory of depression

  • Correspondence
  • Published:
Molecular Psychiatry Submit manuscript

A Correspondence to this article was published on 16 June 2023

The Original Article was published on 20 July 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry. 2022:1–14. https://doi.org/10.1038/s41380-022-01661-0.

  2. Robinson J. The serotonin theory of depression: how the media got it all wrong. Pharmaceutical J. 2022. https://pharmaceutical-journal.com/article/feature/the-serotonin-theory-of-depression-how-the-media-got-it-all-wrong. Accessed 6 October 2022.

  3. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357–66. https://doi.org/10.1016/S0140-6736(17)32802-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Meyniel F, Goodwin GM, Deakin JW, Klinge C, MacFadyen C, Milligan H, et al. A specific role for serotonin in overcoming effort cost. Elife. 2016;5:e17282. https://doi.org/10.7554/eLife.17282.

    Article  PubMed  PubMed Central  Google Scholar 

  5. El-Mallakh RS, Gao Y, Jeannie Roberts R. Tardive dysphoria: the role of long term antidepressant use in-inducing chronic depression. Med Hypotheses. 2011;76:769–73. https://doi.org/10.1016/j.mehy.2011.01.020.

    Article  CAS  PubMed  Google Scholar 

  6. Fava GA. May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance. Ther Adv Psychopharmacol. 2020;10:2045125320970325. https://doi.org/10.1177/2045125320970325.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sleem A, El-Mallakh RS. Adaptive changes to antipsychotics: their consequences and how to avoid them. Curr Psychiatry. 2022;21:46–50. https://doi.org/10.12788/cp.0262.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

RSE did most of the writing, but the ideas originated from all the authors during discussions about the mechanisms of treatment options.

Corresponding author

Correspondence to Rif S. El-Mallakh.

Ethics declarations

Competing interests

RSE receives grant funding from Sunovion, and is a speaker for Axsome, Intracellular, Janssen, Lundbeck, Noven, Otsuka, and Teva. The other authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El-Mallakh, R.S., Doroodgar, M., Elsayed, O.H. et al. The serotonin theory of depression. Mol Psychiatry 28, 3157 (2023). https://doi.org/10.1038/s41380-023-02091-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41380-023-02091-2

  • Springer Nature Limited

This article is cited by

Navigation